chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Autoimmune disorder; Serum sickness; Vertigo; Short term memory loss; This spontaneous case was reported by a physician and describes the occurrence of AUTOIMMUNE DISORDER (Autoimmune disorder) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AUTOIMMUNE DISORDER (Autoimmune disorder) (seriousness criterion medically significant), SERUM SICKNESS (Serum sickness), VERTIGO (Vertigo) and AMNESIA (Short term memory loss). At the time of the report, AUTOIMMUNE DISORDER (Autoimmune disorder), SERUM SICKNESS (Serum sickness), VERTIGO (Vertigo) and AMNESIA (Short term memory loss) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.  Patient was also tested by Neurology.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up information received on 20-JUL-2021 contains significant information - Outcome of the events changed from unknown to recovering/resolving.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested
Area around injection site is quite pronounced and erythematous. Pt's feeling like his throat is "feeling funny" - no trouble breathing (BENADRYL).
I developed diagnosed psoriasis after the second dose of my covid vaccine.  The symptoms is moderate to severe with plague psoriasis through my entire scalp, face, chest, back, arms, legs and throughout body.  I have never had psoriasis but genetic pre-disposed with my father and sister having mild psoriasis or eczema.  Have been prescribed steroid cream, steroid pills and Tacrolimus but has not healed after 3 months of therapy.  Currently will start systemic injections , immunosuppressant biologics) due to the fact that it's spreading and symptoms are not improving.
Had a really headache; Heart raced; Fatigued; Nauseated; Sick; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: EW0217, Expiry Date: Unknown), via an unspecified route of administration in the left arm on 09Jun2021 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that she got the first COVID vaccine on wednesday afternoon (09Jun2021) and within three hours she was sick and still sick. The patient stated that no one else reacted to it that way. She wanted to know if she should go to the hospital, see her doctor or if it was expected. She stated that being sick was that she had a really bad headache and heart raced initially but she has been fatigued and nauseated since then. Patient received Tylenol as a treatment for events. The outcome of the events sick was not recovered, fatigued was recovering, and the rest of the events was recovered on 10Jun2021.  Information on lot/batch number was available. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 11May2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; acyclovir [aciclovir] (ACYCLOVIR [ACICLOVIR]), (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug   Clinical course: COVID-19 treatment included Paxlovid from 03Jan2023 to 08Jan2023. The patient has no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Dizzy in her head; Heart rate increased to around 130; Blood pressure shot up to around 140; head was heavy; If she sat down she would feel it spinning; her adrenaline is really high; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left deltoid on 21Dec2020 at single dose for COVID-19 immunization. The relevant medical history included underweight (she was underweight prior to receiving the vaccine/ She thought based on her BMI she should be 104 pounds at least). Concomitant medications were reported as none. On 21Dec2020, 10 minutes after the patient received the vaccine she felt a little dizzy in her head. Her head was heavy and if she stood up it kind of lessened it. If she sat down she would feel it spinning. Her heart rate also increased to around 130. She had never had issues with vitals. Her blood pressure also shot up to around 140. After she got the vaccine, the doctor there mentioned that her adrenaline was really high. What helped her out was she helped her was walk and pace around for 0.5 hours after she had the symptoms. That helped. Moving around helped. It was almost like she was ready to do a marathon or something like that. She wanted to do something. She could not sit down. When she sat down she would start spinning after walking. Her rate and her blood pressure were not as high the second day. They re-checked her vitals Monday evening and they were still high before she left work. Not as high as right after, but her heart rate was still around 120 and her blood pressure was about 130/80. The outcome of the events "Dizzy in her head", "Heart rate increased to around 130" and "Blood pressure shot up to around 140" was recovered on 22Dec2020, while other events were unknown.  Information about Lot/Batch number has been requested.
hives down both her legs/hives down both arms and both legs/just a little bump here and there; pain in her arm; chills/a little bit of chills; heart racing; anxiety; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives down both her legs/hives down both arms and both legs/just a little bump here and there), PAIN IN EXTREMITY (pain in her arm), PALPITATIONS (heart racing), ANXIETY (anxiety) and CHILLS (chills/a little bit of chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.    Co-suspect product included non-company product OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) (unknown route) 20 mg. On 01-Mar-2021, the patient experienced URTICARIA (hives down both her legs/hives down both arms and both legs/just a little bump here and there), PAIN IN EXTREMITY (pain in her arm) and CHILLS (chills/a little bit of chills). In 2021, the patient experienced PALPITATIONS (heart racing) and ANXIETY (anxiety). At the time of the report, URTICARIA (hives down both her legs/hives down both arms and both legs/just a little bump here and there), PALPITATIONS (heart racing) and ANXIETY (anxiety) had resolved and PAIN IN EXTREMITY (pain in her arm) and CHILLS (chills/a little bit of chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-063165 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-Mar-2021: followup received on 16-mar-2021 significant information was reported On 04-Jun-2021: other manufacture report; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-063165:1st dose
Shortly after vaccination, pt developed nausea and dry heaves. Symptoms lasted appx. 10 minutes before improving. She denied any SOB, tongue/throat swelling, dizziness or other symptoms. HR 78, BP 158/90, SP02: 99%. No signs to suggest anaphylaxis. EMS services and ER evaluation were offered but pt declined. She elected to drive home with her husband.
Severe headache, nausea, vomiting, dizziness, and muscle pain.
abnormal lymph glands under arm; Initial information received on 24-Jan-2022 regarding an unsolicited valid non-serious case was received from the patient.  This case involves an unknown age and unknown gender patient who had abnormal lymph glands under arm, while receiving vaccine INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED [FLUZONE UNSP].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED (strength, formulation, dosage regimen, lot number not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on batch number was requested.   On an unknown date, the patient developed a non-serious event 'abnormal lymph glands under arm' (lymphadenopathy) 3 days following the administration of INFLUENZA USP TRIVAL A-B VACCINE - UNSPECIFIED.  It was reported "They just don't know. I have abnormal lymph glands under my arm found 3 days after flu shot. Have to go in for another scan. Radiologist said they see this a lot w/Covid vaccinations."  Action taken with INFLUENZA VACCINE TRIVALENT (FLUZONE UNSP) was not applicable.  It was not reported if the patient received a corrective treatment for the event (abnormal lymph glands under arm).  At time of reporting, the outcome was Unknown for the event 'abnormal lymph glands under arm'.
nauseous; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (nauseous). At the time of the report, NAUSEA (nauseous) outcome was unknown.            Patient also received 3rd dose (Booster dose)  No concomitant medications were reported  No treatment information was provided   This case was linked to MOD-2021-324183.
The pt received the Moderna vaccine and later came back to the pharmacy and she was flushed and she communicated that there was tightening in her throat, I immediately gave her Benadryl and I also gave her a bottle of water . Pt felt much better after about 20 minutes no tightening in her throat and the flushing was gone.  The rph on duty tomorrow will call and check on the patient.
Loss/missed period, resumed about 3 weeks later with very heavy red bleeding. I am very regular and was concerned I was pregnant and that this causes miscarriage. I tested negative (over the counter) a few days after missed period date.
1 - Sore arm the morning after the vaccine for about a week  2 - On day after vaccine, my heart randomly fluttered & pounded hard (lasted from seconds to minutes).  This was especially bad on the 2nd and 3rd night after the vaccine.  This continued at a lesser scale after the 3rd day.  My heart would sometimes feel shaky or like an involuntary twitch or sometimes jittery (like I was over-caffeinated).  There were a couple of days where I felt it more than others. I went to see my primary doctor because I was concerned about the flutters continuing or getting worse after the 2nd dose of the vaccine.  He performed an EKG and overall advised me to continue forward with the 2nd dose.  ***It is important to note... The flutters/shaking of my heart continued right up to when I went for my 2nd dose of the vaccine.  Upon receiving the 2nd vaccine, it all ceased.  I cannot explain or understand how or why, but they stopped immediately after the 2nd vaccine and I have not had them since.  Very odd!
February 8, 2021 1100- injection  12:30 - localized soreness of injection site 1800 - chills, low grade fever, mild body aches  20:00 - continuous chills, low grade fever. Severe body aches and joint pain. 0600 February 9, 2021 - joint pain/body aches resolved. Took 1000mg of Tylenol every 6 hours which provided relief from the fever and chills. No improvement of joint pain with OTC Tylenol.  All symptoms subsided by Feb 9, 2021 1200.
Both of her thighs had LARGER than golf ball-sized lumps where the injection sites were.    She couldn't walk for a day or two, then could only limp for a couple of weeks. Even though I tried to massage them after a couple of days when she would let me touch them, the lumps did not go down until about a month or more.  Could this mean that her body put a protective bubble around the immunizations like when sometimes an appendix bursts and the poison is encapsulated by a protective covering.  And so then maybe the immunizations weren't as effective in her????  ALSO,COULD THESE LUMPS ALSO BE SCARRING HER MUSCLES??   She seems to be easily allergic to stuff---skin rashes especially....is this related and could this affect her immunity?  It happened in  one of her thighs 5 months earlier and I just reported that too.  but it didn't happen with the hepb or varicella she just received in 8/9/05 and it didn't happen before the first time...
Patient reported vaginal bleeding after she got home.  She explained that this is 3 weeks early from her normal period. I recommended she call her PCP.
Caller reports that they had a temperature excursion 3/31/2023 which they called into the regulatory agency; the products were labeled but still accidentally administered after the new short dated expiration date.; The vaccines were "short dated" and a new expiration date of 6/30/2023 was given.; This spontaneous report was received from an office manager and refers to a patient of no reported age or gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 05-JUL-2023, the patient was vaccinated with an expired and improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, at a dose of 0.5 milliliters, lot # W031816, expiration date: 16-NOV-2022, administered as prophylaxis (strength, vaccination scheme, anatomical location and route of administration were not provided) following a temperature excursion of 6 degree Fahrenheit (F) up to 14 F 4 hours 0 minutes; 14 F up to 46 F 4 hours 0 minutes; 47 F to 77 F (50 F) 3 hours 57 minutes (TOTAL: 11 hours 57 minutes)  (Improper storage of product in use, expired product administered). The vaccine was short-dated, and a new expiration date of 30-JUN-2023 was given, it was mentioned that the vaccine was labeled but still accidentally administered after the new short-dated expiration date (product expiration date issue).  This is one of several cases from the same reporter.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The pharmacist reported that the patient called in the day before reporting and reported that he was experiencing a rash after being vaccinated with SHINGRIX. No additional details were available. The reporter did not consent to follow-up.
Patient notified me that she had pain in arm after one week and it was difficult to do anything without pain. Pain was relieved by anti-inflammatories. Notified me again that it was getting better but still there after 2 weeks - MD prescribed a course of steroids on 11/11/13.
very sore left arm then about 3 hours later fever of 101 ,body aches ,chills and headache .This lasted about 24 hours. Also plus rate was up 90-1120bpm
Immediate memory loss. MRI has been taken with no abnormalities noted. Sugar count went from 116, 120 to 299 and continued through April and May with memory loss that he cannot remember anything within 2 minutes. He has been very confused and repeats the same questions over and over. His blood sugar has been the same for years until the vaccine
arm pain; headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration on 10Feb2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  On an unspecified date in Feb2021 the patient experienced arm pain and headache, non serious. Patient asked if it was okay to take Tylenol for symptoms such as arm pain and headache and if the same applied for ibuprofen. The final outcome of the event was unknown.No follow-up attempts are possible, information about batch number cannot be obtained.
Severe chills first night, followed by extremely hot dehydration. Golf ball sized hot red painful lump at injection site. Swollen lymph nodes in left arm.  Choking on liquids.  Treatment, ice and 50mg of benedryl. Ongoing  Medical account has detailed notes on side effects starting with first shot to booster
High-pitched cry and body stiffening in intermittent episodes, over several hours.  Arm held out in front or overhead.  Recovered the following day, no fever.
Received a dose of Moderna on 08/09/2021 and received a dose of Pfizer-Lot # FC3184 on 10/07/2021.
PATIENT STATES HE HAD NUMBNESS AND TINGLING IN LEGS AND ARMS, CHEST PAIN, FEVER, ACHY
Within 17 minutes of getting the shots, I started having jaw pain. That increased pain for 4 weeks. I had mild left side facial droops. Started having elevated heart rate. I went to the cardiologist on May 30th. I had a heart attack on June 3rd. There was no blockage. I went to the ER. They did not do any test. I could not use or move my legs or my arms before I left. So, they gave me medication for that. They said that there was nothing that they could do. So, I went to back to the ER and they transfer me to the cardiology department. They did EKG and ECHO.
she has got COVID right now, she is vaccinated; she has got COVID right now, she is vaccinated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown) and in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "she has got COVID right now, she is vaccinated". The event "she has got covid right now, she is vaccinated" required physician office visit. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Clinical course: Reporter stated, So I am calling on behalf of my sister, she has got COVID right now, she is vaccinated and her vaccine, the second vaccine (Confirmed as Pfizer covid-19 vaccine) was like 7 months ago. So, anyways right now she has got COVID on day 5 so yesterday was day 4 and she called like her health insurance and they did a virtual exam with a doctor, they set an appointment with the doctor. The doctor prescribed the pill that came out for COVID, the Paxlovid.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Soon after administer-  flushed cheeks- then went home, nausea, urine retention and fever 102-103- condition persisted + Pt. went to ER-fu evaluation next day.
7 days p/flu shot pt devel body aches & general malaise w/sore throat; cramping feeling in muscle of lt arm;
My throat is bad; Swelling underneath arms, face and neck; Swelling underneath arms, face and neck; Swelling underneath arms, face and neck; This is a spontaneous report from a contactable consumer (patient). This 64-year-old (reported as 64.5 years) female patient received the first dose of BNT162B2 (COVID-19 VACCINE, Batch/Lot number: ER8727) at single dose on 24Mar2021 in left arm for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient experienced swelling underneath arms, face and neck. Her throat was bad on an unspecified date. Patient had an adverse reaction to the 1st dose. 48 hours later, face swelled up and was still swelled up, underneath her neck and underneath her arm. Patient was very swelled up and her throat was bad. Patient was supposed to go for 2nd dose on today (15Apr2021), and didn't know if she should get the second dose. The outcome of event throat discomfort was unknown. The outcome of rest events was not recovered. No follow-up attempts are needed. No further information is expected.
Varicella vaccine administered in a local health department clinic on 2/18/09 in the morning to this adolescent female.  Patient had history of undocumented varicella disease in 2001.  For school requirements, patient presented for and received varicella vaccine on 2/18/09. On 2/23/09, Vaccine Administrator received notice from the school nurse that the child had been sent home from school with a generalized maculopapular rash over trunk and both arms, with approximately 40-60 lesions.  Oral temperature was 100.2 degrees.  Mother was notified by the school nurse and was taking child to a physician for evaluation.
Information has been received from a Registered Nurse concerning an 84 year old female patient with a history of breast cancer remission and no drug reactions or allergies who on 21-JAN-2011 was vaccinated with PNEUMOVAX 23 0.5 mL intramuscularly. There was no concomitant therapy. On 21-JAN-2011 the patient experienced swelling at the injection site, and her arm was red and swollen. The patient went to the emergency room and was given ADVIL and BENADRYL. Lab diagnostics included complete blood cell count "CBC test" with no result provided. The patient was recovering from the adverse events. Additional information has been requested.